To examine the potential biological mechanisms of AGAP2-AS1 involved in GBM cells, subcellular fractionation assays were performed to determine the distribution of AGAP2-AS1 in nuclear and cytoplasmic fractions in GBM cells. Here, AGAP2 is linked to glioblastoma.